[Asia Economy Reporter Minji Lee] Aptamer Science announced on the 9th that it has been selected as the lead research institution for the project "Development of COVID-19 Neutralizing Aptamer Therapeutics" under the COVID-19 Therapeutics and Vaccine New Drug Development Consortium.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing